Hanbury Unveils Design for New Novo Nordisk Facility

Marking one of the largest manufacturing investments in Novo Nordisk’s history, the expansion will add 1.4 million square feet of production space for aseptic manufacturing and finished production processes, doubling the combined square footage of all three of the company’s existing facilities. The architectural plan includes an Automated Warehouse, Aseptic and Finished Products Buildings, a Central Utility Building, and an Administrative Building.

With a design that integrates sustainability and state-of-the-art technology, the site strategically places production buildings around a central spine to optimize natural light and reduce visual impact. This layout is enhanced by high-visibility landscapes that blend seamlessly with functional spaces, promoting a connection to the natural environment and improving employee well-being.

Committed to achieving net zero emissions, the facility embodies Novo Nordisk’s 'Circular for Zero' strategy with initiatives like an extensive on-site photovoltaic system, use of off-site renewable energy resources, sourcing of low-carbon concrete and steel, a thorough embodied carbon footprint analysis, and comprehensive strategies for rainwater capture and process water treatment. Every aspect of the site, from the overarching layout to the choice of materials and the indoor environment, has been meticulously designed to align with Novo Nordisk's stringent environmental goals, aiming for LEED Gold certification in the process.


"This facility is a landmark project that truly reflects Novo Nordisk’s commitment to changing the course of chronic disease management through innovative solutions," said Pat O’Keefe, Principal and COO of Hanbury. "It's a testament to how thoughtful architecture can effectively merge functionality with sustainability, ultimately enhancing the quality of life not just for its immediate users but for the global community it serves."

Visuals by Pixelflakes